Search
Showing results for "1"
We are currently taking expressions of interest for CliniSibs in 2024.
We evaluated the immunogenicity and safety of 1 and 2 doses of MenACWY-TT, given alone or co-administered with PCV13 in toddlers.
Meet Winter and Fox. The siblings are the first two participants in Australia to become involved in a new study using continuous glucose monitoring for measuring blood glucose levels in children at high risk of developing type 1 diabetes but who are not yet showing clinical signs of the condition.
The Children’s Diabetes Centre has had a few inquiries about the new BANDIT trial, based in Melbourne, and whether we are involved. Currently, the trial is only open to people who live in Victoria.The Centre is involved in other Australian studies aiming to better understand diabetes.
Our researchers are trying to learn more about the effect different types of food have on blood glucose levels and how to give the best insulin dose to manage a variety of foods.
The aims of this study were to investigate kinin receptor expression on eosinophils of asthmatic and healthy subjects
Anthony and Zavier's mum Lucy talks about her contrasting school experiences in dealing with her sons' type 1 diabetes - with and without the support of the Diabetes in Schools program.
erology, predicting, Pseudomonas aeruginosa infection, young children, cystic fibrosis
The Rio Tinto Children’s Diabetes Centre; A JDRF Global Centre of Excellence (the Centre), announces inaugural Honours Scholarships for students dedicated to type 1 diabetes research.